Literature DB >> 8722530

Antimicrobial resistance and Helicobacter pylori.

A F Goddard1, R P Logan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8722530     DOI： 10.1093/jac/37.4.639

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

1.  In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.

Authors:  J K Akada; M Shirai; K Fujii; K Okita; T Nakazawa
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori.

Authors:  F Szczebara; L Dhaenens; P Vincent; M O Husson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-02       Impact factor: 3.267

3.  New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates.

Authors:  Carla Fontana; Marco Favaro; Silvia Minelli; Anna Angela Criscuolo; Antonio Pietroiusti; Alberto Galante; Cartesio Favalli
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori.

Authors:  J Y Jeong; A K Mukhopadhyay; D Dailidiene; Y Wang; B Velapatiño; R H Gilman; A J Parkinson; G B Nair; B C Wong; S K Lam; R Mistry; I Segal; Y Yuan; H Gao; T Alarcon; M L Brea; Y Ito; D Kersulyte; H K Lee; Y Gong; A Goodwin; P S Hoffman; D E Berg
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

5.  Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Authors:  P Ghiara; M Rossi; M Marchetti; A Di Tommaso; C Vindigni; F Ciampolini; A Covacci; J L Telford; M T De Magistris; M Pizza; R Rappuoli; G Del Giudice
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.

Authors:  G Wang; Q Jiang; D E Taylor
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.

Authors:  G Wang; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.

Authors:  Norazah Ahmad; Wan-Rasinah Zakaria; Sheikh-Anwar Abdullah; Ramelah Mohamed
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

Review 10.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.